WebDisclosure WebDisclosure
Basculer en Français
10349 Companies
215135 Keywords
144978 Articles
113982 Press releases
Headlines Articles Press releases Simcere Pharmaceutical Group Limited Remove
  1. Home
  2. Companies
  3. Simcere Pharmaceutical Group Limited
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 12:00, 3 months 9 days ago

    Boehringer Ingelheim and Simcere Collaborate on IBD Treatment

    Immunology Boehringer Ingelheim Inflammatory Bowel Disease Bispecific Antibody Simcere Partnership
  • BRIEF

    published on 01/27/2026 at 12:00, 3 months 9 days ago

    Boehringer Ingelheim et Simcere collaborent sur le traitement des MII

    Boehringer Ingelheim Immunologie Maladie Inflammatoire De L'intestin Anticorps Bispécifique Partenariat Simcere
  • PRESS RELEASE

    published on 01/27/2026 at 11:55, 3 months 9 days ago

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide
    Boehringer Ingelheim Inflammatory Bowel Disease IBD Simcere Antibody Treatment
    Logo of Simcere Pharmaceutical Group Limited
Accesswire
  • Published on 05/06/2026 at 02:17, 3 hours 37 minutes ago

    Troubadour Announces Share Consolidation and Effective Date

  • Published on 05/06/2026 at 02:00, 3 hours 54 minutes ago

    Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement

  • Published on 05/06/2026 at 02:00, 3 hours 54 minutes ago

    Alset AI Announces Shares for Debt Transaction

  • Published on 05/06/2026 at 01:30, 4 hours 24 minutes ago

    Presentation to RIU Sydney Resources Roundup

  • Published on 05/06/2026 at 01:20, 4 hours 34 minutes ago

    Empress Grants Stock Options and Equity Incentives

View all ACCESSWIRE
EQS Group
  • Published on 05/06/2026 at 03:05, 2 hours 48 minutes ago

    ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group

  • Published on 05/06/2026 at 03:05, 2 hours 48 minutes ago

    Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue

  • Published on 05/06/2026 at 01:35, 4 hours 18 minutes ago

    VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

  • Published on 05/06/2026 at 00:05, 5 hours 48 minutes ago

    ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds

  • Published on 05/05/2026 at 23:05, 6 hours 48 minutes ago

    Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1

View all EQS
Les Echos
  • Published on 05/05/2026 at 19:00, 10 hours 54 minutes ago

    Combined General Meeting of Air Liquide Shareholders of May 5, 2026

  • Published on 05/05/2026 at 19:00, 10 hours 54 minutes ago

    Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026

  • Published on 05/05/2026 at 18:40, 11 hours 14 minutes ago

    Share Buyback program

  • Published on 05/05/2026 at 18:40, 11 hours 14 minutes ago

    Mise en œuvre du programme de rachat d’actions

  • Published on 05/05/2026 at 18:03, 11 hours 51 minutes ago

    Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy